[Federal Register: July 8, 2008 (Volume 73, Number 131)]
[Notices]
[Page 39017-39018]
[DOCID:fr08jy08-71]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Peripheral and Central Nervous System Drugs Advisory Committee;
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
    Name of Committee : Peripheral and Central Nervous System Drugs
Advisory Committee.
    General Function of the Committee : To provide advice and
recommendations to the agency on FDA's regulatory issues.
    Date and Time : The meeting will be held on August 6 and 7, 2008,
from 8 a.m. to5 p.m.
    Location : Hilton Washington DC/Silver Spring, The Ballrooms, 8727
Colesville Rd., Silver Spring, MD. The hotel telephone number is 301-
589-5200.
    Contact Person : Diem-Kieu Ngo, Center for Drug Evaluation and
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for
express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857,
301-827-7001, FAX:<PHONE_NUMBER>, e-mail<EMAIL_ADDRESS>or FDA
Advisory Committee Information Line, 1-800-741-8138<PHONE_NUMBER> in
the Washington, DC area), code<PHONE_NUMBER>. Please call the Information
Line for up-to-date information on this meeting. A notice in the
Federal Register about last minute modifications that impact a
previously announced advisory committee meeting cannot always be
published quickly enough to provide timely notice. Therefore, you
should always check the agency's Web site and call the appropriate
advisory committee hot line/phone line to learn about possible
modifications before coming to the meeting.
    Agenda : On August 6, 2008, the committee will discuss new drug
application (NDA) 20-427, vigabatrin, Ovation Pharmaceuticals, Inc.,
for the proposed indication of adjunctive therapy for the treatment of
refractory complex partial seizures in adults. On August 7, 2008, the
committee will discuss NDA 22-006, vigabatrin, Ovation Pharmaceuticals,
Inc., for the proposed indication of treatment of infantile spasms.
    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/ohrms/dockets/ac/acmenu.htm, click on
the year 2008 and scroll down to the appropriate advisory committee
link.
    Procedure : Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before July
23, 2008. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. on both days. Those desiring to make
formal oral presentations should notify the contact person and submit a
brief statement of the general nature of the evidence or arguments they
wish to present, the names and addresses of proposed participants, and
an indication of the

approximate time requested to make their presentation on or before July
15, 2008. Time allotted for each presentation may be limited. If the
number of registrants requesting to speak is greater than can be
reasonably accommodated during the scheduled open public hearing
session, FDA may conduct a lottery to determine the speakers for the
scheduled open public hearing session. The contact person will notify
interested persons regarding their request to speak by July 16, 2008.
    Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Diem-Kieu Ngo at
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/oc/advisory/
default.htm for procedures on public conduct during advisory committee
meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: June 26, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-15471 Filed 7-7-08; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register: October 8, 2009 (Volume 74, Number 194)]
[Notices]
[Page 51841-51842]
[DOCID:fr08oc09-44]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

October 1, 2009.
    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:
    Docket Numbers: RP93-162-021.
    Applicants: Transcontinental Gas Pipe Line Company, LLC.
    Description: Transcontinental Gas Pipe Line Company, LLC submits
its cash-out report for the annual period 8/1/09 through 7/31/09 and
its reports of cash-out refunds for the Annual Period.
    Filed Date: 09/29/2009.
    Accession Number: 20090929-0102.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Docket Numbers: RP09-317-003.

    Applicants: Texas Gas Transmission, LLC.
    Description: Texas Gas Transmission, LLC submits Substitute Second
Revised Sheet No. 2200 to FERC Gas Tariff, Third Revised Volume No. 1.
    Filed Date: 09/30/2009.
    Accession Number: 20090930-0082.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Docket Numbers: RP09-747-001.
    Applicants: Rockies Express Pipeline LLC.
    Description: Rockies Express Pipeline LLC Substitute First Revised
Sheet No. 250 to its FERC Gas Tariff, Second Revised Volume No. 1.
    Filed Date: 09/30/2009.
    Accession Number: 20090930-0083.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Docket Numbers: RP96-272-097.
    Applicants: Northern Natural Gas Company.
    Description: Northern Natural Gas Company submits Seventeenth
Revised Sheet No. 66B 01 et al to its FERC Gas Tariff, Fifth Revised
Volume No. 1.
    Filed Date: 09/30/2009.
    Accession Number: 20090930-0084.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Docket Numbers: RP00-305-040.
    Applicants: CenterPoint Energy-Mississippi River Transmission
Corporation.
    Description: CenterPoint Energy--Mississippi River Transmission
Corporation submits Third Revised Sheet No. 10D to its FERC Gas Tariff,
Third Revised Volume No. 1.
    Filed Date: 09/28/2009.
    Accession Number: 20090929-0090.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Docket Numbers: RP09-427-002.
    Applicants: Southern Natural Gas Company.
    Description: Southern Natural Gas Company submits Fifth Revised
Sheet No. 1 et al to its FERC Gas Tariff, Seventh Revised Volume No. 1.
    Filed Date: 09/28/2009.
    Accession Number: 20090929-0091.
    Comment Date: 5 p.m. Eastern Time on Tuesday, October 13, 2009.

    Any person desiring to protest this filing must file in accordance
with Rule 211 of the Commission's Rules of Practice and Procedure (18
CFR 385.211). Protests to this filing will be considered by the
Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Such protests
must be filed on or before 5 p.m. Eastern Time on the specified comment
date. Anyone filing a protest must serve a copy of that document on all
the parties to the proceeding.
    The Commission encourages electronic submission of protests in lieu
of paper using the ``eFiling'' link at http://www.ferc.gov. Persons
unable to file electronically should submit an original and 14 copies
of the protest to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    This filing is accessible online at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.

Nathaniel J. Davis, Jr.,
Deputy Secretary.
[FR Doc. E9-24273 Filed 10-7-09; 8:45 am]

BILLING CODE 6717-01-P